Literature DB >> 20358215

Neuromuscular manifestations in hereditary haemochromatosis.

S F Wouthuis1, C Th B M van Deursen, M P te Lintelo, C A M Rozeman, R Beekman.   

Abstract

Involvement of peripheral nerves and skeletal muscles has been reported in the course of hereditary haemochromatosis (HH) but a systematic study is lacking. However, patients with HH report symptoms suggesting a possible polyneuropathy or myopathy. In this study patients with DNA proven HH were recruited from a large general teaching hospital. First, all patients were clinically examined using a structured interview and neurological exam. After reviewing these data an expert panel reached consensus about the presence of a possible neuropathy or myopathy and made recommendations for ancillary investigations (nerve conduction studies, electromyography, thermal threshold tests, laboratory tests). After a second meeting consensus was reached about the final diagnosis. Patients who had a neuropathy or myopathy of which the origin was still unclear were referred to an independent neurologist for further evaluation. Ultimately, of 46 patients included, 25 had no myopathy or neuropathy, 5 an axonal sensory motor polyneuropathy of which the cause was found (diabetes in 2, combination of diabetes and chemotherapy in 1, Charcot Marie Tooth type 2 in 1, Morbus Sjögren in 1), 9 an idiopathic axonal sensory motor polyneuropathy, 3 an idiopathic small fiber polyneuropathy and 4 a carpal tunnel syndrome. There were no cases of proven myopathy. We conclude that an idiopathic polyneuropathy was diagnosed in a relative large number of patients with HH (26%), but the causal relationship needs to be confirmed in larger (case-control) series.

Entities:  

Mesh:

Year:  2010        PMID: 20358215     DOI: 10.1007/s00415-010-5548-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damage.

Authors:  Nicholas J Shaheen; Laura B Lawrence; Bruce R Bacon; James C Barton; Nancy H Barton; Joseph Galanko; Christopher F Martin; Charles K Burnett; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

Review 2.  Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

Authors:  J D England; G S Gronseth; G Franklin; R G Miller; A K Asbury; G T Carter; J A Cohen; M A Fisher; J F Howard; L J Kinsella; N Latov; R A Lewis; P A Low; A J Sumner
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

3.  Sonographically guided percutaneous muscle biopsy in diagnosis of neuromuscular disease: a useful alternative to open surgical biopsy.

Authors:  Paul J O'Sullivan; Grainne M Gorman; Orla M Hardiman; Michael J Farrell; P Mark Logan
Journal:  J Ultrasound Med       Date:  2006-01       Impact factor: 2.153

4.  Thermal testing: normative data and repeatability for various test algorithms.

Authors:  D Yarnitsky; E Sprecher
Journal:  J Neurol Sci       Date:  1994-08       Impact factor: 3.181

5.  Normal Hoffmann reflex latencies (H-M interval) in relation to age and body length.

Authors:  S L Visser; A Zonneveldt; W de Rijke; J A Don; E I Martens; D Stam
Journal:  Clin Neurol Neurosurg       Date:  1983       Impact factor: 1.876

6.  Chronic inflammatory demyelinating polyneuropathy associated with idiopathic hemochromatosis.

Authors:  Sonoko Misawa; Satoshi Kuwabara; Shinji Matsuda; Yumi Sakakibara; Yoshitsugu Ogawa; Jun Tashiro; Takamichi Hattori
Journal:  Intern Med       Date:  2006-08-15       Impact factor: 1.271

7.  Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy.

Authors:  L J Olson; W D Edwards; J T McCall; D M Ilstrup; B J Gersh
Journal:  J Am Coll Cardiol       Date:  1987-12       Impact factor: 24.094

8.  Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients.

Authors:  N C Notermans; J H Wokke; H Franssen; Y van der Graaf; M Vermeulen; L H van den Berg; P R Bär; F G Jennekens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

9.  Idiopathic hemochromatosis (IHC): dementia and ataxia as presenting signs.

Authors:  H R Jones; E T Hedley-Whyte
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

Review 10.  Hereditary hemochromatosis--a new look at an old disease.

Authors:  Antonello Pietrangelo
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

View more
  4 in total

Review 1.  Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

Authors:  Janneke G Hoeijmakers; Catharina G Faber; Giuseppe Lauria; Ingemar S Merkies; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2012-05-29       Impact factor: 42.937

Review 2.  Iron and a Man's Reproductive Health: the Good, the Bad, and the Ugly.

Authors:  J Scott Gabrielsen; Dolores J Lamb; Larry I Lipshultz
Journal:  Curr Urol Rep       Date:  2018-06-01       Impact factor: 3.092

Review 3.  Secondary myopathy due to systemic diseases.

Authors:  J Finsterer; W N Löscher; J Wanschitz; S Quasthoff; W Grisold
Journal:  Acta Neurol Scand       Date:  2016-02-25       Impact factor: 3.209

4.  Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.

Authors:  Moones Heidari; Sam H Gerami; Brianna Bassett; Ross M Graham; Anita C G Chua; Ritambhara Aryal; Michael J House; Joanna F Collingwood; Conceição Bettencourt; Henry Houlden; Mina Ryten; John K Olynyk; Debbie Trinder; Daniel M Johnstone; Elizabeth A Milward
Journal:  Rare Dis       Date:  2016-06-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.